Back to Genetics Birth Defects
Genetics/Birth Defects
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Genetics Birth Defects

Genetics and Birth Defects

An index of genetic conditions, birth defects, and related diagnostic and therapeutic resources.

Alphabetical Index of Conditions and Topics

  • Alpha-1 Antitrypsin Deficiency
  • Ataxia Telangiectasia
  • Birth Defects
  • Brain Malformations
  • Cerebral Palsy
  • Charcot-Marie-Tooth Disease
  • Chiari Malformation
  • Cleft Lip and Palate
  • Cloning
  • Color Blindness
  • Congenital Heart Defects
  • Craniofacial Abnormalities
  • Cystic Fibrosis
  • Down Syndrome
  • Dwarfism
  • Ehlers-Danlos Syndrome
  • Family History
  • Fetal Alcohol Spectrum Disorders
  • Fragile X Syndrome
  • Friedreich Ataxia
  • G6PD Deficiency
  • Gaucher Disease
  • Genes and Gene Therapy
  • Genetic Brain Disorders
  • Genetic Counseling
  • Genetic Disorders
  • Genetic Testing
  • Hemochromatosis
  • Hemophilia
  • Huntington's Disease
  • Hydrocephalus
  • Klinefelter Syndrome
  • Leukodystrophies
  • Marfan Syndrome
  • Metabolic Disorders
  • Muscular Dystrophy
  • Neural Tube Defects
  • Neurofibromatosis
  • Newborn Screening
  • Osteogenesis Imperfecta
  • Phenylketonuria
  • Prader-Willi Syndrome
  • Pregnancy and Medicines
  • Prenatal Testing
  • Rare Diseases
  • Rett Syndrome
  • Sickle Cell Disease
  • Spina Bifida
  • Spinal Muscular Atrophy
  • Tay-Sachs Disease
  • Tourette Syndrome
  • Tuberous Sclerosis
  • Turner Syndrome
  • Usher Syndrome
  • Von Hippel-Lindau Disease
  • Wilson Disease

Frequently Asked Questions

Common prenatal screening options include first‑trimester nuchal translucency ultrasound combined with maternal serum markers, non‑invasive prenatal testing (NIPT) that analyzes fetal DNA in maternal blood, and detailed anatomy ultrasounds around 18‑22 weeks. Diagnostic tests such as chorionic villus sampling (CVS) at 10‑13 weeks or amniocentesis after 15 weeks can provide definitive chromosomal or gene‑level results, with accuracy >99% for conditions like Down syndrome, but they carry a small miscarriage risk (≈0.5‑1%).
Newborn screening panels vary by state but typically cover metabolic, endocrine, hemoglobin, and some genetic disorders (e.g., cystic fibrosis, sickle cell disease, severe combined immunodeficiency). They do not capture structural birth defects or many rare genetic conditions. An abnormal screen prompts confirmatory diagnostic testing (blood, urine, or imaging) and referral to a specialist. Early intervention services should be initiated promptly to improve outcomes.
voiding teratogens is key: stop smoking, limit alcohol, discontinue non‑essential medications, and avoid illicit drugs. Ensure adequate folic acid (400‑800 µg daily) before conception and through the first trimester to lower neural‑tube defect risk. Manage chronic conditions (e.g., diabetes, hypertension) under medical supervision, maintain a balanced diet, and stay up‑to‑date on vaccinations such as rubella.
Recurrence risk depends on the inheritance pattern. For autosomal dominant conditions caused by a new mutation, the risk is usually ~50% if a parent is affected; for autosomal recessive disorders, each subsequent pregnancy has a 25% chance; X‑linked recessive disorders give a 50% risk for carrier mothers and 0% for carrier fathers. Genetic counseling and targeted carrier testing can give precise estimates.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab